Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave s Revenues Up in Q3; CFO to Step Down This Month

NEW YORK, Oct. 27 (GenomeWeb News) - Third Wave Technologies today reported increased revenues and miniscule earnings for the third quarter. The company said its CFO will leave by the end of the month (see this afternoon's PEOPLE column for information about additional personnel changes at Third Wave).

 

Third Wave booked $10.5 million in revenues during the quarter ended Sept. 30, up from $9.4 million during the year-ago quarter.

 

R&D expenses for the quarter stayed flat, at $2.7 million compared to $2.8 million last year.

 

Third Wave's net income totaled $24,000, representing no earnings per share, compared to a net loss of $1.4 million, or $.04 per diluted share, for the same period last year.

 

As of Sept. 30, Third Wave had $67.1 million in cash, cash equivalents, and short-term investments.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.